Gary A. Zarkin
Distinguished Fellow, Behavioral Health
Distinguished Fellow, Behavioral Health
PhD, Economics, University of Chicago
MA, Economics, University of Chicago
BA, Economics, University of Washington
Dr. Zarkin shared what drew him to the field of health economics and substance use.
When I arrived at RTI in 1989 after working on the faculty of Duke University, the federal government was spending a lot of money supporting substance use research. They supported national surveillance surveys like the National Study on Drug Use and Heath (NSDUH), that RTI has conducted since 1988, and studies of the effect of drug treatment. I was trained as a labor economist and had not done any work in the substance use area prior to coming to RTI. In conjunction with several of my RTI colleagues, we developed a methodology to estimate the cost of drug treatment with an initial focus on costing methadone treatment. At that time, there was essentially no one else looking at the cost of drug treatment. Our early work put us in the forefront of cost estimation. We built on our early work and went on to develop an activity-based cost estimation approach that we are still using to estimate the cost of substance use treatment and substance use interventions more generally.
Read More about Prescription Drug Overdose Prevention for States (PfS) Program
To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.